tradingkey.logo

Adapthealth Corp

AHCO
View Detailed Chart
9.540USD
+0.140+1.49%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.29BMarket Cap
17.30P/E TTM

Adapthealth Corp

9.540
+0.140+1.49%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.49%

5 Days

-10.59%

1 Month

+9.66%

6 Months

+11.25%

Year to Date

+0.21%

1 Year

-8.71%

View Detailed Chart

TradingKey Stock Score of Adapthealth Corp

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Adapthealth Corp's Score

Industry at a Glance

Industry Ranking
44 / 209
Overall Ranking
112 / 4608
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Buy
Current Rating
13.250
Target Price
+40.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Adapthealth Corp Highlights

StrengthsRisks
Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.26B.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 17.03, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 141.08M shares, decreasing 8.46% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 162.12K shares of this stock.

Adapthealth Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Adapthealth Corp Info

Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
Ticker SymbolAHCO
CompanyAdapthealth Corp
CEOMs. Suzanne M. Foster
Websitehttps://adapthealth.com/investor-relations/
KeyAI